Cancer Mortality Continued to Decline Through 2022
However, increase seen in incidence in women, especially for middle-aged and younger women
AI-Supported Double Mammogram Reading Improves Detection Rate
Superior breast cancer detection rate seen compared with standard double-reading, without negatively affecting recall rate
Shorter Treatment Regimens Recommended for Tuberculosis
Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB
Rurality Partly Explains Racial Difference in Distance to Lung Cancer Screening
Mean distance in American Indian-majority census tracts reduced with adjustment for rurality but was still 3.16 times that seen in White majority tracts
Nonadherence to Cancer Screening Varies by Screening Type
Life dissatisfaction linked to nonadherence for cervical cancer and breast cancer screenings
AI-Driven Detection of Ovarian Cancer Surpasses Human Expert-Level Accuracy
Transformer-based neural network models surpass diagnostic performance of examiners for identifying ovarian cancer in ultrasound images
PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer
M1 disease detected with PSMA-PET in 46 percent of patients with high-risk, nonmetastatic hormone-sensitive prostate cancer
Position Statement Developed for Managing Blood Cancers in Pregnancy
Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy
Decrease Seen in In Situ Breast Cancer Since 2009
Decrease consistent with decreasing use of screening mammography since 2009 guideline change
Performance, Optimal Combination of MRI Descriptors Explored in Meniere Disease
Zero-point endolymph and negative signal endolymph descriptor combinations classified 95.8 percent of ears
